Glycopyrrolate Injection 0.2mg/mL Vial from Canada
Sterile injectable solution of glycopyrrolate used preoperatively to inhibit salivary secretions and block cardiac vagal activity. Classified under HTS 3004.90.92.57 for medicaments affecting the digestive system in measured doses. It is an unmixed product per chapter notes despite solvent dissolution.
Duty Rate — Canada → United States
100%
Rate breakdown
9903.04.60100%Except as provided in heading 9903.04.61, patented pharmaceutical articles as provided for in subdivisions (c) and (d) of U.S. note 40 to this subchapter
9903.05.860%Articles provided for in subdivision (b) of U.S. note 52 to this subchapter
Import Tips
• Comply with USP <797> sterile compounding standards and provide sterility test reports
• Declare exact glycopyrrolate salt form and concentration to match HTS specificity
• Avoid bulk shipments; ensure pre-filled vials for measured doses to prevent misclassification